The pharmacological study on madecassoside demonstrated that it can effectively lessen the related inflammatory factors in arthritis model rats (TNF-α ↓, IL-1b ↓, IL-6 ↓, IFN-γ ↓, IL-17 ↓). This evidence concerns the gene IL17A and arthritic joint disease.